• Markets
  • icon
  • Companies
CURE · ASX

Global X S&P Biotech ETF (ASX:CURE)

AU$41.67

 0.0 (0.0%)
ASX:Live
08/12/2023 03:47:25 PM
Near Resistance GROWTH AUS All-ETFS
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

CURE Overview

CURE Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About CURE

Telephone

N/A

Address

Description

N/A

CURE Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 34.75 - 45.69

Trade Value (12mth)

AU$13,538.00

1 week

5.76%

1 month

12.29%

YTD

-0.41%

1 year

1.46%

All time high

86.04

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CURE Shortsell

Frequently Asked Questions

The current share price of Global X S&P Biotech ETF (CURE:ASX) is AU$41.67.
The 52-week high share price for Global X S&P Biotech ETF (CURE:ASX) is AU$45.69.
The 52-week low share price for Global X S&P Biotech ETF (CURE:ASX)? is AU$34.75.
Global X S&P Biotech ETF (CURE:ASX) does not pay a dividend.
The last dividend payment of Global X S&P Biotech ETF (CURE:ASX) is AU$0.02.
Global X S&P Biotech ETF (CURE:ASX) does not offer franking credits.
Global X S&P Biotech ETF (CURE:ASX) is classified in the Other Finance.